Articles

A clinical practice comparison of patients with chronic lymphocytic leukemia with and without deletion 17p receiving first-line treatment with ibrutinib

Memorial Sloan Kettering Cancer Center, New York
BeiGene, Ltd., Emeryville
BeiGene, Ltd., Emeryville
BeiGene, Ltd., Emeryville
BeiGene (Beijing) Co., Ltd, Beijing
BeiGene, Ltd., Cambridge
BeiGene, Ltd., Cambridge
BeiGene USA, Inc., San Mateo
Willamette Valley Cancer Institute / US Oncology Research, Eugene
Haematologica Early view Apr 21, 2022 https://doi.org/10.3324/haematol.2021.280376